News & Investors
29. November 2019 - 16:13 (CEST)
New Micro-Simulation Study in Cancer Medicine Finds Epi proColon® Provides Clinically Meaningful Reductions in Incidence and Mortality of Colorectal Cancer
Read more19. November 2019 - 9:04 (CEST)
Epigenomics AG Reports Financial Results for the First Nine Months 2019
Read more15. November 2019 - 10:51 (CEST)
Epigenomics AG Announces Conference Call with Authors Presenting at the European Public Health Conference
Read more05. November 2019 - 8:32 (CEST)
Epigenomics AG: No operational reasons for sharp decline in share price
Read more31. October 2019 - 10:33 (CEST)
